Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 46801-46850 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05302934
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
N/A
Recruiting
600 participants
Started: Sep 28, 2022 · Completed: Mar 31, 2027
6 conditions
1 sponsor
4 locations
NCT05587569
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
NA
Recruiting
80 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2030
2 conditions
1 sponsor
9 locations
NCT05562791
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
PHASE1
Recruiting
20 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05544864
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
NA
Recruiting
376 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2026
2 conditions
4 sponsors
5 locations
NCT05378035
DOAC in Chinese Patients With Atrial Fibrillation
N/A
Recruiting
427 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2027
7 conditions
1 sponsor
1 location
NCT05415397
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
PHASE3
Recruiting
140 participants
Started: Sep 28, 2022 · Completed: Jul 31, 2026
2 conditions
2 sponsors
1 location
NCT05417776
Collagen-targeted PET Imaging for Early Interstitial Lung Disease
PHASE2
Recruiting
30 participants
Started: Sep 28, 2022 · Completed: Apr 1, 2026
1 condition
2 sponsors
1 location
NCT05918549
Movement Analysis in Musculoskeletal Oncology: a Pilot Study
N/A
Recruiting
30 participants
Started: Sep 28, 2022 · Completed: Sep 28, 2024
1 condition
3 sponsors
1 location
NCT05578807
Total Tubeless Percutaneous Nephrolithotomy Without a Ureteral Catheter
NA
Recruiting
100 participants
Started: Sep 28, 2022 · Completed: Jan 10, 2025
2 conditions
1 sponsor
1 location
NCT05427240
eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
NA
Recruiting
1,000 participants
Started: Sep 28, 2022 · Completed: Jan 31, 2026
1 condition
3 sponsors
1 location
NCT05660811
Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients
PHASE4
Recruiting
80 participants
Started: Sep 28, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT05670301
Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic Diseases
NA
Recruiting
2,500 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2029
3 conditions
6 sponsors
7 locations
NCT05568953
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity
PHASE2
Recruiting
70 participants
Started: Sep 28, 2022 · Completed: Oct 31, 2025
4 conditions
2 sponsors
1 location
NCT05514158
To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG)
PHASE1
Recruiting
24 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT05525858
KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
N/A
Recruiting
1,000 participants
Started: Sep 28, 2022 · Completed: Mar 31, 2027
3 conditions
3 sponsors
32 locations
NCT05794217
A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
N/A
Recruiting
20,000 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05491551
Alcohol-ROC-Training
NA
Recruiting
177 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2027
4 conditions
2 sponsors
1 location
NCT05391126
GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
NA
Recruiting
178 participants
Started: Sep 28, 2022 · Completed: May 31, 2027
2 conditions
1 sponsor
1 location
NCT05483335
Assessing Burnout in Medical Students in Clerkship Years in United Arab Emirates
N/A
Recruiting
132 participants
Started: Sep 28, 2022 · Completed: Jun 30, 2024
3 conditions
1 sponsor
1 location
NCT05555459
Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation
NA
Recruiting
125 participants
Started: Sep 28, 2022 · Completed: Nov 30, 2028
19 conditions
1 sponsor
1 location
NCT04088422
Cell Free DNA in Mature B-cell Lymphoma
N/A
Recruiting
320 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05419934
EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial
NA
Recruiting
60 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05480930
Improving Nighttime Access to Care and Treatment; Part 4-Haiti
NA
Recruiting
7,124 participants
Started: Sep 27, 2022 · Completed: Sep 30, 2027
2 conditions
2 sponsors
1 location
NCT06148610
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
N/A
Recruiting
170 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2024
3 conditions
16 sponsors
1 location
NCT05513365
Phase II Dutasteride in Combination With CAB vs CAB in SDC
PHASE2
Recruiting
26 participants
Started: Sep 27, 2022 · Completed: Sep 30, 2027
1 condition
2 sponsors
1 location
NCT05171075
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
PHASE3
Recruiting
1,020 participants
Started: Sep 27, 2022 · Completed: Feb 28, 2027
3 conditions
2 sponsors
185 locations
NCT05241405
Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer
NA
Recruiting
354 participants
Started: Sep 27, 2022 · Completed: Sep 30, 2027
2 conditions
3 sponsors
10 locations
NCT05725200
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
PHASE2
Recruiting
40 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2040
1 condition
1 sponsor
1 location
NCT05629494
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
PHASE4
Recruiting
198 participants
Started: Sep 27, 2022 · Completed: Dec 1, 2026
3 conditions
1 sponsor
3 locations
NCT05503264
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
PHASE3
Recruiting
152 participants
Started: Sep 27, 2022 · Completed: Dec 14, 2029
2 conditions
2 sponsors
87 locations
NCT05528952
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
PHASE2
Recruiting
105 participants
Started: Sep 27, 2022 · Completed: Feb 27, 2030
1 condition
3 sponsors
14 locations
NCT05736848
A Retrospective Assessment of OviTex PRS (OviTex)
N/A
Recruiting
200 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
11 locations
NCT05687565
Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV
NA
Recruiting
27 participants
Started: Sep 27, 2022 · Completed: Dec 21, 2025
1 condition
1 sponsor
1 location
NCT05556044
Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction
PHASE3
Recruiting
200 participants
Started: Sep 27, 2022 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT05532696
Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients
PHASE1/PHASE2
Recruiting
61 participants
Started: Sep 27, 2022 · Completed: May 31, 2027
3 conditions
1 sponsor
5 locations
NCT05682131
South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol
PHASE4
Recruiting
210 participants
Started: Sep 27, 2022 · Completed: Sep 27, 2030
2 conditions
14 sponsors
1 location
NCT06190782
Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
PHASE3
Recruiting
354 participants
Started: Sep 27, 2022 · Completed: Sep 27, 2027
3 conditions
1 sponsor
1 location
NCT05526235
A Scalable Psychological Intervention to Reduce Psychological Distress Among Workers of Assisted Living Facilities
NA
Recruiting
150 participants
Started: Sep 27, 2022 · Completed: Sep 30, 2024
3 conditions
3 sponsors
1 location
NCT05384691
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
PHASE2
Recruiting
213 participants
Started: Sep 27, 2022 · Completed: Jul 31, 2027
2 conditions
2 sponsors
22 locations
NCT05761392
APP-based Precise Management System of Chronic Intractable Pain
NA
Recruiting
120 participants
Started: Sep 26, 2022 · Completed: Sep 25, 2026
2 conditions
1 sponsor
1 location
NCT05991219
Screening and Secondary Prevention Rheumatic Heart Disease Study
N/A
Recruiting
5,000 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT05290051
Prospective Study to Assess Medical Performance of Optical Mapping and Long Read Sequencing in Detecting Numerical and Structural Chromosome Abnormalities
NA
Recruiting
400 participants
Started: Sep 26, 2022 · Completed: Jun 26, 2026
4 conditions
10 sponsors
1 location
NCT05679583
Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer
PHASE2
Recruiting
25 participants
Started: Sep 26, 2022 · Completed: Sep 25, 2026
1 condition
1 sponsor
1 location
NCT05102396
Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?
PHASE2
Recruiting
17 participants
Started: Sep 26, 2022 · Completed: Aug 30, 2024
7 conditions
2 sponsors
1 location
NCT05572788
Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts
NA
Recruiting
600 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05563012
Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma
PHASE2
Recruiting
29 participants
Started: Sep 26, 2022 · Completed: Oct 1, 2026
1 condition
1 sponsor
1 location
NCT05397210
Post-market Clinical Follow-up (PMCF) Study of the Infinity-Lock Button System for Acromioclavicular Joint Stabilisation
N/A
Recruiting
58 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
6 locations
NCT07147673
fNIRS Grasping Task in Infants
N/A
Recruiting
100 participants
Started: Sep 26, 2022 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT05292092
Essential Pro PMCF Study ( rEPIC04E )
N/A
Recruiting
176 participants
Started: Sep 26, 2022 · Completed: Aug 30, 2025
2 conditions
1 sponsor
7 locations
NCT04777656
Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients.
PHASE3
Recruiting
120 participants
Started: Sep 26, 2022 · Completed: Nov 30, 2026
1 condition
3 sponsors
4 locations
Previous
1
More pages
934
935
936
937
938
939
940
More pages
1333
Next